SCHEDULE 3PARTICULARS AND DOCUMENTS THAT MUST ACCOMPANY AN APPLICATION FOR AN ETHICS COMMITTEE OPINION, A REQUEST FOR AUTHORISATION, A NOTICE OF AMENDMENT AND A NOTIFICATION OF THE CONCLUSION OF A TRIAL
PART 2REQUEST FOR AUTHORISATION
8
1
The address of any premises at which any batch of finished investigational medicinal products to be used in the clinical trial has been, or is to be, checked in accordance with F2regulation 43(2) or Article 13(3) of the Directive.
F12
If an investigational medicinal product to be used in the clinical trial has been, or is to be—
a
imported into Great Britain from a country other than Northern Ireland or imported into Northern Ireland from a country other than an EEA State, a statement from the qualified person at the disposal of the person holding the manufacturing authorisation in relation to that importation specifying—
i
the address of any premises outside the United Kingdom at which the product was manufactured or assembled; and
ii
the manufacturing or assembling operations performed at those premises;
b
imported into Northern Ireland from an EEA State, a statement from the qualified person at the disposal of the person holding the authorisation referred to in Article 13 of the Directive in relation to that importation specifying—
i
the address of any premises outside the European Economic Area at which the product was manufactured or assembled; and
ii
the manufacturing or assembling operations performed at those premises.